Home page > Products > Curosurf®

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data

Curosurf®

active ingredient: Poractant alfa
Patient leaflet
Summary of Product Characteristics

80 mg /ml, suspension for intratracheal and bronchoalveolar administration
Fraction of phospholipids from the lungs of the pig

 

 

 

Content on the www.chiesi.pl website is for informational purposes only and can not be considered as a form of medical consultation and may not replace a doctor's consultation to which the final decision on the manner and scope of treatment is appropriate.